Risk Factors for Venous Thromboembolism in Kidney Transplant Recipients Identified
Venous thromboembolism occurred in the graft in 15.4% of patients.
Venous thromboembolism occurred in the graft in 15.4% of patients.
Vitamin K deficiency is common among kidney transplant recipients.
“Pressures, such as outcomes reporting and perceived inadequate risk adjustment, disincentivize transplant programs from using high KDPI kidneys,” investigator says.
Although slow graft function does not necessitate dialysis, it is associated with a higher risk for graft failure and patient death, according to investigators.
Providers’ response to patient non-adherence was partly informed by their experiences working with patients, the training they received, and their own implicit biases, according to investigators.
Kidney transplant recipients with bacteremia may be more likely to require outpatient parenteral antibiotics if the infection is caused by bacteria that produce extended-spectrum beta-lactamases.
Patients aged 65 years or older had significant 84% lower odds of being waitlisted for a first transplant compared with patients aged 18 to 64 years.
The safety profile of SGLT2 inhibitors in kidney transplant recipients with type 2 diabetes is similar to that of other patient populations, new research suggests.
How outcomes differ between recipients of deceased vs living donor kidneys of advanced age needs to be studied further.
Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects.